Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis

NCT04948840 is registered in ClinicalTrials.gov with Centre Francois Baclesse, Luxembourg as lead sponsor.

NCT NCT04948840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04948840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis
Lead sponsor
Centre Francois Baclesse, Luxembourg
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2022
Completion date
December 31, 2024
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, fibrosis, radiation toxicity